Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bladder and Bowel Dysfunction in Children
NCT05318365Recruiting
- Sponsor
- Aarhus University
- Start
- Sep 2022
- Primary completion
- Dec 2025
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
Randomised, open-label trial of polyethylene glycol 3350 in bladder and bowel dysfunction (BBD), urinary incontinence (UI), nocturnal enuresis (NE) and 2 more (2 arms), sponsored by Aarhus University. Primary endpoint: Number of participants with reduction in weekly episodes of urinary incontinence at 3 months. Started Sep 2022; status: recruiting.
02
Drugs
polyethylene glycol 3350
03
Conditions
bladder and bowel dysfunction (BBD)urinary incontinence (UI)nocturnal enuresis (NE)constipationfecal incontinence (FI)
Beyond the preview
Go deeper on NCT05318365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05318365.